Simcere Zaiming and TargetRx agree TGRX-326 commercial rights

Simcere Zaiming has entered a collaboration deal with Shenzhen TargetRx to bring TGRX-326 to the Chinese market.

Sep 4, 2024 - 04:00

Simcere Zaiming and TargetRx agree TGRX-326 commercial rights

Simcere Zaiming has entered a collaboration deal with Shenzhen TargetRx to bring TGRX-326 to the Chinese market.

Read the original article

Tags:

Previous Article

UK NHS launches vaccine programme for RSV

Why the Importer of Record (IoR) is vital in the clinical supply chain

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

FDA accepts Shorla’s oral liquid leukaemia drug NDA

FDA accepts Shorla’s oral liquid leukaemia drug NDA

Apr 9, 2024

Biden shakes up US drug pricing landscape with inflation-related penalties

Biden shakes up US drug pricing landscape with inflatio...

Dec 16, 2023

Opinion: The amoxicillin shortage continues to force pediatricians and families to scramble

Opinion: The amoxicillin shortage continues to force pe...

May 9, 2023